October 2024 – Birmingham, Michigan –CitySide Ventures and Birmingham Angels announce addingM3D Imaging to its portfolio of companies. Our Birmingham Angels investors participated in the company’s $1.5M Seed round alongside a few other Michigan early-stage groups.
Radiation is used through healthcare to image and treat patients. The radioactive drugs have advanced in the last five years and will continue to do so, but the tools used by hospitals and clinics to safely administer are stuck in the 20th century. M3D line of products enables surgeons, physicians and nuclear medicine teams to more precisely, safely and quickly administer, clean up and perform surgery. The technology is already established as a market leader in other industries and we are developing a line of products and software that are designed for healthcare workers.
“We are thrilled to welcome M3D Imaging to our portfolio. Very impressive team and another example of Michigan innovation. We anticipate great things to come.”– Doron York, CEO & Chief Investment Officer, CitySide Ventures.